1 |
Kazakova SV, Hageman JC, Matava M, Srinivasan A, Phelan L, Garfinkel B, et al. 2005. A clone of methicillin-resistant Staphylococcus aureus among professional football players. N. Engl. J. Med. 352: 468-475.
DOI
|
2 |
Sen S, Sirobhushanam S, Johnson SR, Song Y, Tefft R, Gatto C, et al. 2016. Growth-environment dependent modulation of Staphylococcus aureus branched-chain to straight-chain fatty acid ratio and incorporation of unsaturated fatty acids. PLoS One 11: e0165300.
DOI
|
3 |
Fernandes A, Nascimento TC, Jacob-Lopes E, De Rosso V, Zepka L. 2018. Introductory Chapter: Carotenoids - A brief overview on its structure, biosynthesis, synthesis, and applications, 1: 1-16, Ed.
|
4 |
Palma M, Cheung AL. 2001. Sigma(B) activity in Staphylococcus aureus is controlled by RsbU and an additional factor(s) during bacterial growth. Infect. Immun. 69: 7858-7865.
DOI
|
5 |
Liu Y, Wu N, Dong J, Gao Y, Zhang X, Shao N, et al. 2010. SsrA (tmRNA) acts as an antisense RNA to regulate Staphylococcus aureus pigment synthesis by base pairing with crtMN mRNA. FEBS Lett. 584: 4325-4329.
DOI
|
6 |
Kullik I, Giachino P, Fuchs T. 1998. Deletion of the alternative sigma factor σB in Staphylococcus aureus reveals its function as a global regulator of virulence genes. J. Bacteriol. 180: 4814-4820.
DOI
|
7 |
van Schaik W, Abee T. 2005. The role of σB in the stress response of Gram-positive bacteria - targets for food preservation and safety. Curr. Opin. Biotechnol. 16: 218-224.
DOI
|
8 |
Katzif S, Lee E-H, Law AB, Tzeng Y-L, Shafer WM. 2005. CspA regulates pigment production in Staphylococcus aureus through a SigB-dependent mechanism. J. Bacteriol. 187: 8181-8184.
DOI
|
9 |
Lan L, Cheng A, Dunman PM, Missiakas D, He C. 2010. Golden pigment production and virulence gene expression are affected by metabolisms in Staphylococcus aureus. J. Bacteriol. 192: 3068-3077.
DOI
|
10 |
Cushnie TP, Lamb AJ. 2005. Antimicrobial activity of flavonoids. Int. J. Antimicrob. Agents 26: 343-356.
DOI
|
11 |
Bukowski M, Wladyka B, Dubin G. 2010. Exfoliative toxins of Staphylococcus aureus. Toxins 2: 1148-1165.
DOI
|
12 |
Tsompanidou E, Denham EL, Becher D, de Jong A, Buist G, van Oosten M, et al. 2013. Distinct roles of phenol-soluble modulins in spreading of Staphylococcus aureus on wet surfaces. Appl. Environ. Microbiol. 79: 886-895.
DOI
|
13 |
Schwartz K, Syed AK, Stephenson RE, Rickard AH, Boles BR. 2012. Functional amyloids composed of phenol soluble modulins stabilize Staphylococcus aureus biofilms. PLoS Pathog. 8: e1002744.
DOI
|
14 |
Wang R, Khan BA, Cheung GY, Bach TH, Jameson-Lee M, Kong KF, et al. 2011. Staphylococcus epidermidis surfactant peptides promote biofilm maturation and dissemination of biofilm-associated infection in mice. J. Clin. Invest. 121: 238-248.
DOI
|
15 |
Lobanovska M, Pilla G. 2017. Focus: Drug development: Penicillin's discovery and antibiotic resistance: Lessons for the future? Yale J. Biol. Med. 90: 135.
|
16 |
Hennekinne JA, De Buyser ML, Dragacci S. 2012. Staphylococcus aureus and its food poisoning toxins: characterization and outbreak investigation. FEMS Microbiol. Rev. 36: 815-836.
DOI
|
17 |
Rooijakkers SH, Ruyken M, Van Roon J, Van Kessel KP, Van Strijp JA, Van Wamel WJ. 2006. Early expression of SCIN and CHIPS drives instant immune evasion by Staphylococcus aureus. Cell. Microbiol. 8: 1282-1293.
DOI
|
18 |
Mishra NN, Liu GY, Yeaman MR, Nast CC, Proctor RA, McKinnell J, et al. 2011. Carotenoid-related alteration of cell membrane fluidity impacts Staphylococcus aureus susceptibility to host defense peptides. Antimicrob. Agents Chemother. 55: 526-531.
DOI
|
19 |
Craig EA, Schlesinger MJ. 1985. The heat shock respons. Critc. Rev. Biochem. 18: 239-280.
DOI
|
20 |
Wang R, Braughton KR, Kretschmer D, Bach T-HL, Queck SY, Li M, et al. 2007. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat. Med. 13: 1510-1514.
DOI
|
21 |
Fey PD, Endres JL, Yajjala VK, Widhelm TJ, Boissy RJ, Bose JL, et al. 2013. A genetic resource for rapid and comprehensive phenotype screening of nonessential Staphylococcus aureus genes. mBio 4: e00537-00512.
|
22 |
Parsek MR, Singh PK. 2003. Bacterial biofilms: an emerging link to disease pathogenesis. Ann. Rev. Microbiol. 57: 677-701.
DOI
|
23 |
Lin C-F, Chen C-L, Huang W-C, Cheng Y-L, Hsieh C-Y, Wang C-Y, et al. 2010. Different types of cell death induced by enterotoxins. Toxins 2: 2158-2176.
DOI
|
24 |
McKevitt AI, Bjornson GL, Mauracher CA, Scheifele DW. 1990. Amino acid sequence of a deltalike toxin from Staphylococcus epidermidis. Infect. Immun. 58: 1473-1475.
DOI
|
25 |
Balaban N, Rasooly A. 2000. Staphylococcal enterotoxins. Int. J. Food Microbiol. 61: 1-10.
DOI
|
26 |
Rosenbach AJF. 1884. Mikro-organismen bei den Wund-infections-krankheiten des Menschen, Ed. JF Bergmann.
|
27 |
Anderson KL, Roberts C, Disz T, Vonstein V, Hwang K, Overbeek R, et al. 2006. Characterization of the Staphylococcus aureus heat shock, cold shock, stringent, and SOS responses and their effects on log-phase mRNA turnover. J. Bacteriol. 188: 6739-6756.
DOI
|
28 |
Costerton JW, Stewart PS, Greenberg EP. 1999. Bacterial bio-films: a common cause of persistent infections. Science 284: 1318-1322.
DOI
|
29 |
Scherr TD, Heim CE, Morrison JM, Kielian T. 2014. Hiding in plain sight: interplay between staphylococcal biofilms and host immunity. Front. Immunol. 5: 37.
DOI
|
30 |
Fitzpatrick F, Humphreys H, O'Gara JP. 2005. Evidence for icaADBC-independent biofilm development mechanism in methicillin-resistant Staphylococcus aureus clinical isolates. J. Clin. Microbiol. 43: 1973-1976.
DOI
|
31 |
Yarets Y, Rubanov L, Novikova I, Shevchenko N. 2013. The biofilm-forming capacity of Staphylococcus aureus from chronic wounds can be useful for determining Wound-Bed Preparation methods. EWMA J. 13: 7-14.
|
32 |
Otto M. 2008. Staphylococcal biofilms. Curr. Topics Microbiol. Immunol. 322: 207-228.
|
33 |
Mirani ZA, Aziz M, Khan MN, Lal I, ul Hassan N, Khan SI. 2013. Biofilm formation and dispersal of Staphylococcus aureus under the influence of oxacillin. Microb. Pathog. 61: 66-72.
DOI
|
34 |
Rooijakkers SH, van Kessel KP, van Strijp JA. 2005. Staphylococcal innate immune evasion. Trends Microbiol. 13: 596-601.
DOI
|
35 |
Rooijakkers SH, van Wamel WJ, Ruyken M, van Kessel KP, van Strijp JA. 2005. Anti-opsonic properties of staphylokinase. Microb. Infect. 7: 476-484.
DOI
|
36 |
Al Refaii A, Alix JH. 2009. Ribosome biogenesis is temperature-dependent and delayed in Escherichia coli lacking the chaperones DnaK or DnaJ. Mol. Microbiol. 71: 748-762.
DOI
|
37 |
Lee LYL, Hook M, Haviland D, Wetsel RA, Yonter EO, Syribeys P, et al. 2004. Inhibition of complement activation by a secreted Staphylococcus aureus protein. J. Infect. Dis. 190: 571-579.
DOI
|
38 |
de Haas CJ, Veldkamp KE, Peschel A, Weerkamp F, Van Wamel WJ, Heezius EC, et al. 2004. Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J. Exp. Med. 199: 687-695.
DOI
|
39 |
Kiedrowski MR, Horswill AR. 2011. New approaches for treating staphylococcal biofilm infections. Annal. NY Acad. Sci. 1241: 104-121.
DOI
|
40 |
Hu B, Mayer MP, Tomita M. 2006. Modeling Hsp70-mediated protein folding. Biophys. J. 91: 496-507.
DOI
|
41 |
Singh VK, Sirobhushanam S, Ring RP, Singh S, Gatto C, Wilkinson BJ. 2018. Roles of pyruvate dehydrogenase and branchedchain α-keto acid dehydrogenase in branched-chain membrane fatty acid levels and associated functions in Staphylococcus aureus. J. Med. Microbiol. 67: 570.
DOI
|
42 |
Kakutani Y. 1967. Detection of some isoprenoids and the influence of diphenylamine on the biosynthesis of isoprenoid by Sporobolomyces shibatanus. J. Biochem. 61: 193-198.
DOI
|
43 |
Hammond RK, White DC. 1970. Inhibition of vitamin K2 and carotenoid synthesis in Staphylococcus aureus by diphenylamine. J. Bacteriol. 103: 611-615.
DOI
|
44 |
No JH, de Macedo Dossin F, Zhang Y, Liu Y-L, Zhu W, Feng X, et al. 2012. Lipophilic analogs of zoledronate and risedronate inhibit Plasmodium geranylgeranyl diphosphate synthase (GGPPS) and exhibit potent antimalarial activity. Proc. Natl. Acad. Sci. USA 109: 4058-4063.
DOI
|
45 |
Song Y, Liu CI, Lin FY, No JH, Hensler M, Liu YL, et al. 2009. Inhibition of staphyloxanthin virulence factor biosynthesis in Staphylococcus aureus: in vitro, in vivo, and crystallographic results. J. Med. Chem. 52: 3869-3880.
DOI
|
46 |
Chen F, Di H, Wang Y, Cao Q, Xu B, Zhang X, et al. 2016. Small-molecule targeting of a diapophytoene desaturase inhibits S. aureus virulence. Nat. Chem. Biol. 12: 174-179.
DOI
|
47 |
Hammond RK, White DC. 1970. Inhibition of vitamin K2 and carotenoid synthesis in Staphylococcus aureus by diphenylamine. J. Bacteriol. 103: 611-615.
DOI
|
48 |
Kong C, Neoh HM, Nathan S. 2016. Targeting Staphylococcus aureus toxins: A potential form of anti-virulence therapy. Toxins 8: 72.
DOI
|
49 |
Hall JW, Yang J, Guo H, Ji Y. 2017. The Staphylococcus aureus AirSR two-component system mediates reactive oxygen species resistance via transcriptional regulation of staphyloxanthin production. Infect. Immun. 85: e00838-00816.
|
50 |
Wang Y, Chen F, Di H, Xu Y, Xiao Q, Wang X, et al. 2016. Discovery of Potent benzofuran-derived diapophytoene desaturase (CrtN) inhibitors with enhanced oral bioavailability for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections. J. Med. Chem. 59: 3215-3230.
DOI
|
51 |
Voyich JM, Otto M, Mathema B, Braughton KR, Whitney AR, Welty D, et al. 2006. Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J. Infect. Dis. 194: 1761-1770.
DOI
|
52 |
Vandenesch F, Lina G, Henry T. 2012. Staphylococcus aureus hemolysins, bi-component leukocidins, and cytolytic peptides: a redundant arsenal of membrane-damaging virulence factors? Front. Cell. Infect. Microbiol. 2: 12.
|
53 |
Lin Y-C, Peterson ML. 2010. New insights into the prevention of staphylococcal infections and toxic shock syndrome. Exp. Rev. Clin. Pharmacol. 3: 753-767.
DOI
|
54 |
Chowdhury T. 2014. Virtual screening of compounds derived from Garcinia pedunculata as an inhibitor of gamma hemolysin component A of Staphylo-coccus aureus. Bangladesh J. Pharmacol. 9: 67-71.
DOI
|
55 |
Genestier A-L, Michallet M-C, Prevost G, Bellot G, Chalabreysse L, Peyrol S, et al. 2005. Staphylococcus aureus Panton-Valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils. J. Clin. Investig. 115: 3117-3127.
DOI
|
56 |
Sonnen AF, Henneke P. 2013. Role of pore-forming toxins in neonatal sepsis. Clin. Dev. Immunol. 2013: 608456.
DOI
|
57 |
Popov I, Kaprel'iants A, Ostrovskil D, Ignatov V. 1976. Study of the membranes of pigment-free mutant of Staphylococcus aureus. Biokhimiia (Moscow, Russia). 41: 1116-1120.
|
58 |
Mitchell G, Fugere A, Gaudreau KP, Brouillette E, Frost EH, Cantin AM, et al. 2013. SigB is a dominant regulator of virulence in Staphylococcus aureus small-colony variants. PLoS One 8: e65018.
DOI
|
59 |
Lee J-H, Park J-H, Cho MH, Lee J. 2012. Flavone reduces the production of virulence factors, staphyloxanthin and α-Hemolysin, in Staphylococcus aureus. Curr. Microbiol. 65: 726-732.
DOI
|
60 |
Nanra JS, Buitrago SM, Crawford S, Ng J, Fink PS, Hawkins J, et al. 2013. Capsular polysaccharides are an important immune evasion mechanism for Staphylococcus aureus. Hum. Vaccin. Immunother. 9: 480-487.
DOI
|
61 |
Limsuwan S, Voravuthikunchai SP. 2008. Boesenbergia pandurata (Roxb.) Schltr., Eleutherine americana Merr. and Rhodomyrtus tomentosa (Aiton) Hassk. as antibiofilm producing and antiquorum sensing in Streptococcus pyogenes. FEMS Immunol. Med. Microbiol. 53: 429-436.
DOI
|
62 |
Saising J, Hiranrat A, Mahabusarakam W, Ongsakul M, Voravuthikunchai SP. 2008. Rhodomyrtone from Rhodomyrtus tomentosa (Aiton) Hassk. as a natural antibiotic for Staphylococcal Cutaneous infections. J. Health Sci. 54: 589-595.
DOI
|
63 |
Leejae S, Hasap L, Voravuthikunchai SP. 2013. Inhibition of staphyloxanthin biosynthesis in Staphylococcus aureus by rhodomyrtone, a novel antibiotic candidate. J. Med. Microbiol. 62: 421-428.
DOI
|
64 |
Sakai K, Koyama N, Fukuda T, Mori Y, Onaka H, Tomoda H. 2012. Search method for inhibitors of Staphyloxanthin production by methicillin-resistant Staphylococcus aureus. Biol. Pharm. Bull. 35: 48-53.
DOI
|
65 |
Fukuda T, Tomoda H. 2013. Tylopilusin C, a new diphenolic compound from the fruiting bodies of Tylopilus eximinus. J. Antibiot. 66: 355-357.
DOI
|
66 |
Miller LG, Diep BA. 2008. Clinical practice: colonization, fomites, and virulence: rethinking the pathogenesis of community-associated methicillin-resistant Staphylococcus aureus infection. Clin. Infect. Dis. 46: 752-760.
DOI
|
67 |
Fukuda T, Shinkai M, Sasaki E, Nagai K, Kurihara Y, Kanamoto A, et al. 2015. Graphiumins, new thiodiketopiperazines from the marine-derived fungus Graphium sp. OPMF00224. J. Antibiot. 68: 620-627.
DOI
|
68 |
Pelz A, Wieland K-P, Putzbach K, Hentschel P, Albert K, Gotz F. 2005. Structure and biosynthesis of staphyloxanthin from Staphylococcus aureus. J. Biol. Chem. 280: 32493-32498.
DOI
|
69 |
Aires de Sousa M, de Lencastre H. 2004. Bridges from hospitals to the laboratory: genetic portraits of methicillin-resistant Staphylococcus aureus clones. FEMS Immunol. Med. Microbiol. 40: 101-111.
DOI
|
70 |
Lowy FD. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339: 520-532.
DOI
|
71 |
Gould D, Chamberlaine A. 1995. Staphylococcus aureus: a review of the literature. J. Clin. Nurs. 4: 5-12.
DOI
|
72 |
Fukuda T, Shimoyama K, Nagamitsu T, Tomoda H. 2014. Synthesis and biological activity of Citridone A and its derivatives. J. Antibiot. 67: 445-450.
DOI
|
73 |
Novick RP. 2003. Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol. Microbiol. 48: 1429-1449.
DOI
|
74 |
Baba T, Takeuchi F, Kuroda M, Yuzawa H, Aoki K-I, Oguchi A, et al. 2002. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 359: 1819-1827.
DOI
|
75 |
De la Fuente-Nunez C, Reffuveille F, Fernandez L, Hancock RE. 2013. Bacterial biofilm development as a multicellular adaptation: antibiotic resistance and new therapeutic strategies. Curr. Opin. Microbiol. 16: 580-589.
DOI
|
76 |
Burnside K, Lembo A, de Los Reyes M, Iliuk A, Binhtran NT, Connelly JE, et al. 2010. Regulation of hemolysin expression and virulence of Staphylococcus aureus by a serine/threonine kinase and phosphatase. PLoS One 5: e11071.
DOI
|
77 |
Holten KB, Onusko EM. 2000. Appropriate prescribing of oral beta-lactam antibiotics. Am. Fam. Physician 62: 611-620.
|
78 |
Linares J. 2001. The VISA/GISA problem: therapeutic implications. Clin. Microbiol. Infect. 7 Suppl 4: 8-15.
DOI
|
79 |
Garcia LG, Lemaire S, Kahl BC, Becker K, Proctor RA, Denis O, et al. 2013. Antibiotic activity against small-colony variants of Staphylococcus aureus: review of in vitro, animal and clinical data. J. Antimicrob. Chemother. 68: 1455-1464.
DOI
|
80 |
Foster TJ. 2004. The Staphylococcus aureus "superbug". J. Clin. Investig. 114: 1693-1696.
DOI
|
81 |
Zhu Y. 2010. Staphylococcus aureus virulence factors synthesis is controlled by central metabolism. Dissertations & Theses in Veterinary and Biomedical Science. 5.
|
82 |
Lowy FD. 1998. Staphylococcus aureus infections. New Engl. J. Med. 339: 520-532.
DOI
|
83 |
Siems W, Wiswedel I, Salerno C, Crifo C, Augustin W, Schild L, et al. 2005. β-Carotene breakdown products may impair mitochondrial functions-potential side effects of high-dose β-carotene supplementation. J. Nutr. Biochem. 16: 385-397.
DOI
|
84 |
Bien J, Sokolova O, Bozko P. 2011. Characterization of virulence factors of Staphylococcus aureus: Novel function of known virulence factors that are implicated in activation of airway epithelial proinflammatory response. J. Pathog. 2011: 601905.
DOI
|
85 |
Geoghegan JA, Corrigan RM, Gruszka DT, Speziale P, O'Gara JP, Potts JR, et al. 2010. Role of surface protein SasG in biofilm formation by Staphylococcus aureus. J. Bacteriol. 192: 5663-5673.
DOI
|
86 |
Bayer AS, Prasad R, Chandra J, Koul A, Smriti M, Varma A, et al. 2000. In vitro resistance of Staphylococcus aureus to thrombin-induced platelet microbicidal protein is associated with alterations in cytoplasmic membrane fluidity. Infect. Immun. 68: 3548-3553.
DOI
|
87 |
O'Riordan K, Lee JC. 2004. Staphylococcus aureus capsular polysaccharides. Clin. Microbiol. Rev. 17: 218-234.
DOI
|
88 |
Sabat A, Melles DC, Martirosian G, Grundmann H, van Belkum A, Hryniewicz W. 2006. Distribution of the serine-aspartate repeat protein-encoding sdr genes among nasal-carriage and invasive Staphylococcus aureus strains. J. Clin. Microbiol. 44: 1135-1138.
DOI
|
89 |
Clarke SR, Andre G, Walsh EJ, Dufrene YF, Foster TJ, Foster SJ. 2009. Iron-regulated surface determinant protein A mediates adhesion of Staphylococcus aureus to human corneocyte envelope proteins. Infect. Immun. 77: 2408-2416.
DOI
|
90 |
Clarke SR, Foster SJ. 2008. IsdA protects Staphylococcus aureus against the bactericidal protease activity of apolactoferrin. Infect. Immun. 76: 1518-1526.
DOI
|
91 |
Nilsson I-M, Lee JC, Bremell T, Ryden C, Tarkowski A. 1997. The role of staphylococcal polysaccharide microcapsule expression in septicemia and septic arthritis. Infect. Immun. 65: 4216-4221.
DOI
|
92 |
Gomez MI, Lee A, Reddy B, Muir A, Soong G, Pitt A, et al. 2004. Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1. Nat. Med. 10: 842-848.
DOI
|
93 |
Sau S, Bhasin N, Wann ER, Lee JC, Foster TJ, Lee CY. 1997. The Staphylococcus aureus allelic genetic loci for serotype 5 and 8 capsule expression contain the type-specific genes flanked by common genes. Microbiology 143: 2395-2405.
DOI
|
94 |
Donlan RM, Costerton JW. 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15: 167-193.
DOI
|
95 |
Bischoff M, Dunman P, Kormanec J, Macapagal D, Murphy E, Mounts W, et al. 2004. Microarray-based analysis of the Staphylococcus aureus σB regulon. J. Bacteriol. 186: 4085-4099.
DOI
|
96 |
Ribeiro D, Freitas M, Silva AM, Carvalho F, Fernandes E. 2018. Antioxidant and pro-oxidant activities of carotenoids and their oxidation products. Food Chem. Toxicol. 120: 681-699.
DOI
|
97 |
Liu GY, Essex A, Buchanan JT, Datta V, Hoffman HM, Bastian JF, et al. 2005. Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. J. Exp. Med. 202: 209-215.
DOI
|
98 |
Foster TJ, Geoghegan JA, Ganesh VK, Hook M. 2014. Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus. Nat. Rev. Microbiol. 12: 49-62.
DOI
|
99 |
George NP, Wei Q, Shin PK, Konstantopoulos K, Ross JM. 2006. Staphylococcus aureus adhesion via Spa, ClfA, and SdrCDE to immobilized platelets demonstrates shear-dependent behavior. Arterioscler. Thromb. Vasc. Biol. 26: 2394-2400.
DOI
|
100 |
Weinstein L, Fields BN. 1982. Seminars in infectious disease, 2: 256-303. Ed. Stratton Intercontinental Medical Book Corporation.
|
101 |
Wieland B, Feil C, Gloria-Maercker E, Thumm G, Lechner M, Bravo JM, et al. 1994. Genetic and biochemical analyses of the biosynthesis of the yellow carotenoid 4,4'-diaponeurosporene of Staphylococcus aureus. J. Bacteriol. 176: 7719-7726.
DOI
|
102 |
Clauditz A, Resch A, Wieland K-P, Peschel A, Gotz F. 2006. Staphyloxanthin plays a role in the fitness of Staphylococcus aureus and its ability to cope with oxidative stress. Infect. Immun. 74: 4950-4953.
DOI
|
103 |
Beard-Pegler MA, Stubbs E, Vickery AM. 1988. Observations on the resistance to drying of staphylococcal strains. J. Med. Microbiol. 26: 251-255.
DOI
|
104 |
Fang FC. 2004. Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat. Rev. Microbiol. 2: 820-832.
DOI
|
105 |
Marshall JH, Wilmoth GJ. 1981. Proposed pathway of triterpenoid carotenoid biosynthesis in Staphylococcus aureus: evidence from a study of mutants. J. Bacteriol. 147: 914-919.
DOI
|
106 |
Liu GY, Essex A, Buchanan JT, Datta V, Hoffman HM, Bastian JF, et al. 2005. Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. J. Exp. Med. 202: 209-215.
DOI
|
107 |
Liu C-I, Liu GY, Song Y, Yin F, Hensler ME, Jeng W-Y, et al. 2008. A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence. Science 319: 1391-1394.
DOI
|
108 |
Arciola CR, Campoccia D, Speziale P, Montanaro L, Costerton JW. 2012. Biofilm formation in Staphylococcus implant infections. A review of molecular mechanisms and implications for biofilm-resistant materials. Biomaterials 33: 5967-5982.
DOI
|
109 |
Kullik I, Giachino P, Fuchs T. 1998. Deletion of the alternative sigma factor is sigma B Staphylococcus aureus reveals its function as a global regulator of virulence genes. J. Bacteriol. 180: 4814-4820.
DOI
|
110 |
Giachino P, Engelmann S, Bischoff M. 2001. Sigma B activity depends on RsbU in Staphylococcus aureu. J. Bacteriol. 183: 1843-1852.
DOI
|
111 |
Muto CA, Jernigan JA, Ostrowsky BE, Richet HM, Jarvis WR, Boyce JM, et al. 2003. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect. Control Hosp. Epidemiol. 24: 362-386.
DOI
|